Portal Instruments is pleased to be showcasing its latest drug delivery platform at the LSI conference in California next week. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact.
Portal Instruments will be showcasing its newest drug delivery platform at the prestigious Life Science Intelligence (LSI) conference in California next week. The company plans to showcase its latest injector platform, representing a significant advancement in reusable injectors. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact on the industry. This appearance at LSI marks an important milestone for Portal as it continues to expand its market presence and forge strategic partnerships within the healthcare ecosystem. Industry experts and potential investors are encouraged to schedule meetings with the Portal team to explore collaboration opportunities and witness firsthand how their innovations are addressing critical challenges in medical delivery systems.
June 30, 2022 - Logan Merrill has taken testosterone injections for 6 years. In this piece, Logan talks about his transition and the process of taking his injections. This blog was written by Logan Merrill for Portal Instruments. All opinions and experiences shared are entirely his own.
June 30, 2021 - The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹
November 2, 2021 - Jody was diagnosed with Scleritis, a serious eye disease that is often associated with an underlying autoimmune disorder. Fast forward to today, Jody has started taking weekly injections to ease her symptoms. We sat down with Jody to hear about her first at home injection.
Please fill out the details below and we will get back to you shortly.